# Effect of Dobutamine on Hepatic Blood Flow During Goal-directed Hemodynamic Therapy

> **NCT04893655** · PHASE4 · COMPLETED · sponsor: **University Hospital, Ghent** · enrollment: 58 (actual)

## Conditions studied

- General Anesthesia

## Interventions

- **DRUG:** Dobutamine Hydrochloride

## Key facts

- **NCT ID:** NCT04893655
- **Lead sponsor:** University Hospital, Ghent
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-09-14
- **Primary completion:** 2023-07-24
- **Final completion:** 2023-07-25
- **Target enrollment:** 58 (ACTUAL)
- **Last updated:** 2023-08-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04893655

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04893655, "Effect of Dobutamine on Hepatic Blood Flow During Goal-directed Hemodynamic Therapy". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04893655. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*